☆ 4.4 Review

Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer

SEMINARS IN ONCOLOGY (2002)

Get Full Text
Add to Collection

Journal

SEMINARS IN ONCOLOGY
Volume 29, Issue 3, Pages 11-21

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/sonc.2002.34049

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.